Cargando…
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
Systemic lupus erythematosus is a highly complex and heterogeneous autoimmune disease mostly mediated by B cells. It is characterized by circulating self-reactive antibodies that deposit and form immune complexes in kidney, leading to irreparable tissue damage and resulting in lupus nephritis. In a...
Autores principales: | Guiteras, Jordi, Ripoll, Élia, Bolaños, Núria, De Ramon, Laura, Fontova, Pere, Lloberas, Núria, Cruzado, Josep Maria, Aràn, Josep Maria, Aviñó, Anna, Eritja, Ramon, Gomà, Montse, Taco, Rosario, Grinyó, Josep Maria, Torras, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105598/ https://www.ncbi.nlm.nih.gov/pubmed/33996261 http://dx.doi.org/10.1016/j.omtn.2021.03.019 |
Ejemplares similares
-
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models
por: Guiteras, Jordi, et al.
Publicado: (2022) -
Erratum to: JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016) -
JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016) -
CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013) -
Correction: CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013)